A Fresh Look at R&D Decisions: Learning from the Best Jason LeBoeuf and Marc Drucker Originally published: 2012 (PDMA Visions Magazine • Issue 2, 2012 • Vol 36 • No 2) Read time: 10 minutes The R&D Manager’s Dilemma Consider this: You are the research and development (R&D) manager tasked with making the business-critical decision of which new product development programs your organization will pursue
Goldense, Bradford L., "More R&D or just more processes?
More R&D or just more processes? [A85].pdf
Goldense, Bradford L., "Top 5 R&D-Product Development Metrics," Machine Design , May 8, 2014, Volume 86, Number 5, Page 46, ISSN 0024-9114
Top 5 R&D-Product Development Metrics [A89].pdf
Goldense, Bradford L., "Top 5 R&D-Product Development Metrics," Machine Design, May 8, 2014, Volume 86, Number 5, Page 46, ISSN 0024-9114
Hybrid R&D: The Path to Breakthrough Innovation Mark Adkins, Smart Hammer Innovation Originally presented: May 1, 2014 Watch time: 32 minutes Access the Webcast Mark Adkins, NPDP, founder & president of Smart Hammer Innovation, shares his experiences of breakthrough innovations being developed at companies recognized as outstanding corporate innovators. This webcast is designed for individuals that are in organizations that are characterized by: An idea-to-launch process that is so refined, that breakthrough innovation ideas may not be advanced Typically, all available funding is committed to core products Breakthrough products are required to enable abundant growth in the future Topics that Mark will discuss include how to restructure a traditional R&D group to include the role of commercial managers and why a robust Stage Zero is critical to filter and promote breakthrough ideas. Walk away from this webcast with important action items: Construct an organizational chart for a Hybrid R&D group Sketch a process model that will guide Hybrid R&D activities Set Key Performance Indicators (KPI’s) for the new organization What did you think of this post?
Premature R&D alliance termination and shareholder returns: Evidence from the biopharmaceutical industry Hadi Eslami, Kamran Eshghi, Farhad Sadeh kHUB post date: June 28, 2023 Originally published: January 30, 2023 (PDMA JPIM • Vol 40, Issue 3 • May 2023) Read time: 45 minutes Access the Full Article Prior research has highlighted the performance implications of R&D alliances for innovation outcomes and the financial returns of firms. However, research on R&D alliances has yet to offer insights into how the premature termination of such alliances, before fulfilling their predetermined innovation objectives, affects the shareholder returns of the firm. Applying transaction cost economics (TCE) theory and real options (RO) logic to a post-formation alliance setting, we posit that premature termination of R&D alliances prompts relative volatility in investors' prospective benefits and risks
Goldense, Bradford L., "The 54th R&D 100 Awards: Invention & Innovation," Machine Design , February 2017, Volume 89, Number 2, Page 64, ISSN 0024-9114
The 54th R&D 100 Awards - Invention & Innovation [A130].pdf
Goldense, Bradford L., "The 54th R&D 100 Awards: Invention & Innovation," Machine Design, February 2017, Volume 89, Number 2, Page 64, ISSN 0024-9114
Goldense, Bradford L., "R&D Spending: The Hype of Emerging Technologies," Machine Design , May 2018, Volume 90, Number 5, Page 96, ISSN 0024-9114
R&D Spending - The Hype of Emerging Technologies [A147].pdf